Differential expression and regulation of anti-hypertrophic genes Npr1 and Npr2 during β-adrenergic receptor activation-induced hypertrophic growth in rats

Molecular and Cellular Endocrinology

Volumn 433, Issue , 2016, Pages 117-129

  Manivasagam, Senthamizharasi ^a   Subramanian, Vimala ^a   Tumala, Anusha ^a   Vellaichamy, Elangovan ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Cardiac hypertrophy; CGMP; Natriuretic peptide receptors; Natriuretic peptides; adrenergic signaling

Indexed keywords

ATENOLOL; ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR; CYCLIC GMP; GUANYLATE CYCLASE; ISOPRENALINE; NATRIURETIC PEPTIDE RECEPTOR A; NATRIURETIC PEPTIDE RECEPTOR B; NATRIURETIC PEPTIDE TYPE C; ATRIAL NATRIURETIC FACTOR RECEPTOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; NPR1 GENE; NPR2 GENE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; UPREGULATION; ANIMAL; GENETICS; HEART; HYPERTROPHY; PHYSIOLOGY; SIGNAL TRANSDUCTION; WISTAR RAT;

ANIMALS; ATRIAL NATRIURETIC FACTOR; CYCLIC GMP; DOWN-REGULATION; GUANYLATE CYCLASE; HEART; HYPERTROPHY; MALE; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ATRIAL NATRIURETIC FACTOR; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84973439791     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2016.06.010     Document Type: Article

References (60)

1. Anand-Srivastava M.B. Atrial Natriuretic Peptide C- receptor and membrane signaling in hypertension. J. Hypertens. 1997, 15(8):815-826.
2. Anand-Srivastava M.B. Natriuretic peptide receptor-C signaling and regulation. Peptides 2005, 26(6):1044-1059.
3. 1-adrenoceptors in normotensive and hypertensive rats. Front. Neurol. 2014, 5(51):1-10.
4. Bianciotti L.G., Vatta M.S., Elverdin J.C., Di Carlo M.B., Negri G., Fernandez B.E. Atrial natriuretic factor-induced amylase output in the rat parotid gland appears to be mediated by the inositol phosphate pathway. Biochem. Biophys. Res. Commun. 1998, 247(1):123-128.
5. Bloch K.D., Seidman J.G., Naftilan J.D., Fallon J.T., Seidman C.E. Neonatal atria and ventricles secrete atrial natriuretic factor via tissue-specific secretory pathways. Cell 1986, 47(5):695-702.
6. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72(1-2):284-285.
7. Bristow M.R. Treatment of chronic heart failure with β-adrenergic receptor antagonists a convergence of receptor pharmacology and clinical cardiology. Circ. Res. 2011, 109(10):1176-1194.
8. Conrad C.H., Brooks W.W., Hayes J.A., Sen S., Robinson K.G., Bing O.H. Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rat. Circulation 1995, 91(1):161-170.
9. Creemers E.E., Wilde A.A., Pinto Y.M. Heart failure: advances through genomics. Nat. Rev. Genet. 2011, 12(5):357-362.
10. Dickey D.M., Flora D.R., Bryan P.M., Xu X., Chen Y., Potter L.R. Differential regulation of membrane guanylyl cyclases in congestive heart failure: natriuretic peptide receptor (NPR)-B, Not NPR-A, is the predominant natriuretic peptide receptor in the failing heart. Endocrinol 2007, 148(7):3518-3522.
11. Dickey D.M., Dries D.L., Margulies K.B., Potter L.R. Guanylylcyclase (GC)-A and GC-B activities in ventricles and cardiomyocytes from failed and non-failed human hearts: GC-A is inactive in the failed cardiomyocyte. J. Mol. Cell Cardiol. 2012, 52(3):727-732.
12. Doyle D.D., Upshaw-Earley J., Bell E.L., Palfrey H.C. Natriuretic peptide receptor-B in adult rat ventricle is predominantly confined to the nonmyocyte population. Am. J. Physiol. Heart Circ. Physiol. 2002, 282(6):H2117-H2123.
13. Garbers D.L., Koesling D., Schultz G. Guanylyl cyclase receptors. Mol. Biol. Cell 1994, 5(1):1.
14. Gopi V., Parthasarathy A., Umadevi S., Vellaichamy E. Angiotensin-II down-regulates cardiac natriuretic peptide receptor-A mediated anti-hypertrophic signaling in experimental rat hearts. Indian J. Exp. Biol. 2013, 51(1):48-55.
15. Gopi V., Subramanian V., Manivasagam S., Vellaichamy E. Angiotensin II down-regulates natriuretic peptide receptor-A expression and guanylyl cyclase activity in H9c2 (2-1) cardiac myoblast cells: role of ROS and NF-κB. Mol. Cell Biochem. 2015, 409(1-2):67-79.
16. Grimm D., Elsner D., Schunkert H., Pfeifer M., Griese D., Bruckschlegel G., Kromer E.P. Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system. Cardiovasc Res. 1998, 37(1):91-100.
17. Hawkridge A.M., Heublein D.M., Bergen H.R., Cataliotti A., Burnett J.C., Muddiman D.C. Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(48):17442-17447.
18. Hayashi D., Kudoh S., Shiojima I., Zou Y., Harada K., Shimoyama M., Nagai R. Atrial natriuretic peptide inhibits cardiomyocyte hypertrophy through mitogen-activated protein kinase phosphatase-1. Biochem. Biophys. Res. Commun. 2004, 322(1):310-319.
19. Kishimoto I., Tokudome T., Nakao K., Kangawa K. Natriuretic peptide system: an overview of studies using genetically engineered animal models. FEBS J. 2011, 278(11):1830-1841.
20. Knowles J.W., Esposito G., Mao L., Hagaman J.R., Fox J.E., Smithies O., Maeda N. Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice. J. Clin. Investig. 2001, 107(8):975-984.
21. Kuwahara K., Nishikimi T., Nakao K. Transcriptional regulation of the fetal cardiac gene program. J. Pharmacol. Sci. 2012, 119(3):198-203.
22. Langenickel T.H., Buttgereit J., Pagel-Langenickel I., Lindner M., Monti J., Beuerlein K., Dietz R. Cardiac hypertrophy in transgenic rats expressing a dominant-negative mutant of the natriuretic peptide receptor B. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(12):4735-4740.
23. Lopez M.J., Garbers D.L., Kuhn M. The guanylylcyclase-deficient mouse defines differential pathways of natriuretic peptide signaling. J. Biol. Chem. 1997, 272(37):23064-23068.
24. Lumsden N.G., Khambata R.S., Hobbs A.J. C-type natriuretic peptide (CNP): cardiovascular roles and potential as a therapeutic target. Curr. Pharm. Des. 2010, 16(37):4080.
25. Mitsuyama S., Takeshita D., Obata K., Zhang G.X., Takaki M. Left ventricular mechanical and energetic changes in long-term isoproterenol-induced hypertrophied hearts of SERCA2a transgenic rats. J. Mol. Cell Cardiol. 2013, 59:95-106.
26. Mori T., Hayashi T., Sohmiya K., Okuda N., Shimomura H., Ohkita M., Kitaura Y. Mechanisms of combined treatment with celiprolol and candesartan for ventricular remodeling in experimental heart failure. Circulation 2005, 69(5):596-602.
27. Nakaoka H.I.D.E.A.K.I., Kitahara Y.O.U.N.O.S.U.K.E., Amano M.A.S.A.O., Imataka K.O.U.J.I., Fujii J., Ishibashi M., Yamaji T. Effect of betaadrenergic receptor blockade on atrial natriuretic peptide in essential hypertension. Hypertension 1987, 10(2):221-225.
28. Nunn C., Zou M.X., Sobiesiak A.J., Roy A.A., Kirshenbaum L.A., Chidiac P. RGS2 inhibits β-adrenergic receptor-induced cardiomyocyte hypertrophy. Cell signal 2010, 22(8):1231-1239.
29. Oliver P.M., Fox J.E., Kim R., Rockman H.A., Kim H.S., Reddick R.L., Maeda N. Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc. Natl. Acad. Sci. U. S. A. 1997, 94(26):14730-14735.
30. Pandey K.N. Biology of natriuretic peptides and their receptors. Peptides 2005, 26(6):901-932.
31. Pandey K.N. Functional roles of short sequence motifs in the endocytosis of membrane receptors. Front Biosci. 2009, 14:5339.
32. Pandey K.N. Guanylyl cyclase/atrial natriuretic peptide receptor-A: role in the pathophysiology of cardiovascular regulation. Can. J. Physiol. Pharmacol. 2011, 89(8):557-573.
33. Pandey K.N. Guanylyl cyclase/natriuretic peptide receptor-A signaling antagonizes phosphoinositide hydrolysis, Ca2+ release, and activation of protein kinase C. Front. Mol. Neurosci. 2014, 7:75.
34. Pandey K.N., Nguyen H.T., Li M., Boyle J.W. Natriuretic peptide receptor-A negatively regulates mitogen-activated protein kinase and proliferation of mesangial cells: role of cGMP-dependent protein kinase. Biochem. Biophys. Res. Commun. 2000, 271(2):374-379.
35. Parthasarathy A., Gopi V., Umadevi S., Simna A., Sheik M.J.Y., Divya H., Vellaichamy E. Suppression of atrial natriuretic peptide/natriuretic peptide receptor-A-mediated signaling upregulates angiotensin-II-induced collagen synthesis in adult cardiac fibroblasts. Mol. Cell Biochem. 2013, 378(1-2):217-228.
36. Ping H., Shen F.M., Xie H.H., Chen Y.Y., Miao C.Y., Mehta J.L., Su D.F. The combination of atenolol and amlodipine is better than their monotherapy for preventing end-organ damage in different types of hypertension in rats. J. Cell Mol. Med. 2009, 13(4):726-734.
37. Potter L.R., Abbey-Hosch S., Dickey D.M. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr. Rev. 2006, 27(1):47-72.
38. Qvigstad E., Moltzau L.R., Aronsen J.M., Nguyen C.H., Hougen K., Sjaastad I., Levy F.O., Skomedal T., Osnes J.B. Natriuretic peptides increase beta1-adrenoceptor signalling in failing hearts through phosphodiesterase 3 inhibition. Cardiovasc Res. 2010, 85(4):763-772.
39. Remondino A., Kwon S.H., Communal C., Pimentel D.R., Sawyer D.B., Singh K., Colucci W.S. β- Adrenergic receptor-stimulated apoptosis in cardiac myocytes is mediated by reactive oxygen species/c-Jun NH2-terminal kinase-dependent activation of the mitochondrial pathway. Circ. Res. 2003, 92(2):136-138.
40. Rona G. Catecholamine cardiotoxicity. J. Mol. Cell Cardiol. 1985, 17(4):291-306.
41. Rose R.A., Giles W.R. Natriuretic peptide C receptor signalling in the heart and vasculature. J. Physiol. 2008, 586(2):353-366.
42. Ruskoaho H. Cardiac hormones as diagnostic tools in heart failure. Endocr. Rev. 2003, 24(3):341-356.
43. Saito Y. Roles of atrial natriuretic peptide and its therapeutic use. J. Cardiol. 2010, 56(3):262-270.
44. Schiebinger R.J. Calcium, its role in isoproterenol-stimulated atrial natriuretic peptide secretion by superfused rat atria. Circ. Res. 1989, 65(3):600-606.
45. Schulz S. C-type natriuretic peptide and guanylylcyclase B receptor. Peptides 2005, 26(6):1024-1034.
46. Senzaki H., Smith C.J., Juang G.J., Isoda T., Mayer S.P., Ohler A., Kass D.A. Cardiac phosphodiesterase 5 (cGMP-specific) modulates β-adrenergic signaling in vivo and is down-regulated in heart failure. FASEB J. 2001, 15(10):1718-1726.
47. Shi S.J., Vellaichamy E., Chin S.Y., Smithies O., Navar L.G., Pandey K.N. Natriuretic peptide receptor A mediates renal sodium excretory responses to blood volume expansion. Am. J. Physiol. Ren. Physiol. 2003, 285(4):F694-F702.
48. Suga S.I., Nakao K., Itoh H., Komatsu Y., Ogawa Y., Hama N., Imura H. Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of vascular natriuretic peptide system. Eur. J. Clin. Investig. 1992, 90(3):1145.
49. Tan X., Li J., Wang X., Chen N., Cai B., Wang G., Yang F. Tanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathway. Int. J. Biol. Sci. 2011, 7(3):383-389.
50. Thibault G., Nemer M., Drouin J., Lavigne J.P., Ding J., Charbonneau C., Sole M. Ventricles as a major site of atrial natriuretic factor synthesis and release in cardiomyopathic hamsters with heart failure. Circ. Res. 1989, 65(1):71-82.
51. Tokudome T., Horio T., Soeki T., Mori K., Kishimoto I., Suga S.I., Kangawa K. Inhibitory effect of C-type natriuretic peptide (CNP) on cultured cardiac myocyte hypertrophy: interference between CNP and endothelin-1 signaling pathways. Endocrinology 2004, 145(5):2131-2140.
52. Tsutamoto T., Wada A., Maeda K., Hisanaga T., Maeda Y., Fukai D., Kinoshita M. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997, 96(2):509-516.
53. Vellaichamy E., Sommana N.K., Pandey K.N. Reduced cGMP signaling activates NF-κB in hypertrophied hearts of mice lacking natriuretic peptide receptor-A. Biochem. Biophys. Res. Commun. 2005, 327(1):106-111.
54. Vellaichamy E., Khurana M.L., Fink J., Pandey K.N. Involvement of the NF-κB/matrix metalloproteinase pathway in cardiac fibrosis of mice lacking guanylyl cyclase/natriuretic peptide receptor A. J. Biol. Chem. 2005, 280(19):19230-19242.
55. Vellaichamy E., Zhao D., Somanna N., Pandey K.N. Genetic disruption of guanylyl cyclase/natriuretic peptide receptor-A upregulates ACE and AT1 receptor gene expression and signaling: role in cardiac hypertrophy. Physiol. Genomics 2007, 31(2):193-202.
56. Vellaichamy E., Das S., Subramanian U., Maeda N., Pandey K.N. Genetically altered mutant mouse models of guanylyl cyclase/natriuretic peptide receptor-A exhibit the cardiac expression of proinflammatory mediators in a gene-dose-dependent manner. Endocrinol 2014, 155(3):1045-1056.
57. Venkatesan B., Tumala A., Subramanian V., Vellaichamy E. Transient silencing of Npr3 gene expression improved the circulatory levels of atrial natriuretic peptides and attenuated β-adrenoceptor activation-induced cardiac hypertrophic growth in experimental rats. Eur. J. Pharmacol. 2016, 782:44-58.
58. Werner F., Kojonazarov B., Gadner B., Abezer M., Schuh K., Völker K., Kuhn M. Endothelial actions of atrial natriuretic peptide prevent pulmonary hypertension in mice. Basic Res. Cardiol. 2016, 111(2):1-16.
59. Yoshimoto T., Naurse M., Tanabe A., Naruse K., Seiki T., Imaki T., Muraki T., Matusda Y., Demura H. Potentiation of Natriuretic Peptide action by the β-adrenergic blocker carvedilol in hypertensive rats: a new antihypertensive mechanism. Endocrinol 1998, 139:81-88.
60. Zhang G.X., Kimura S., Nishiyama A., Shokoji T., Rahman M., Yao L., Abe Y. Cardiac oxidative stress in acute and chronic isoproterenol-infused rats. Cardiovasc Res. 2005, 65(1):230-238.